GFR, Body Mass Index, and Low High-Density Lipoprotein Concentration in Adults With and Without CKD

American Journal of Kidney Diseases

Volumn 50, Issue 4, 2007, Pages 552-558

  Lo, Joan C ^a,b   Go, Alan S ^a,b   Chandra, Malini ^a   Fan, Dongjie ^a   Kaysen, George A ^c,d,e  

^a DIVISION OF RESEARCH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e VA NORTHERN CALIFORNIA HEALTH CARE SYSTEM   (United States)

Author keywords

Chronic kidney disease; dyslipidemia; high density lipoprotein (HDL) cholesterol; obesity

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GLOMERULUS FILTRATION RATE; HEALTH CARE DELIVERY; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; OBESITY; PROTEINURIA; RENAL REPLACEMENT THERAPY;

ADOLESCENT; ADULT; AGED; BODY MASS INDEX; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CROSS-SECTIONAL STUDIES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; OBESITY;

EID: 34548850324     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2007.07.011     Document Type: Article

References (28)

1. Clinical Guidelines on the Identification, Evaluation and Treatment of Overweight and Obesity in Adults: The Evidence Report. NIH Publication No 98-4083 (1998), National Institutes of Health, Bethesda, MD
2. Young C.E., Karas R.H., and Kuvin J.T. High-density lipoprotein cholesterol and coronary heart disease. Cardiol Rev 12 (2004) 107-119
3. Muntner P., He J., Astor B.C., Folsom A.R., and Coresh J. Traditional and nontraditional risk factors predict coronary heart disease in chronic kidney disease: Results from the Atherosclerosis Risk in Communities Study. J Am Soc Nephrol 16 (2005) 529-538
4. Fox C.S., Larson M.G., Leip E.P., Culleton B., Wilson P.W., and Levy D. Predictors of new-onset kidney disease in a community-based population. JAMA 291 (2004) 844-850
5. Gelber R.P., Kurth T., Kausz A.T., et al. Association between body mass index and CKD in apparently healthy men. Am J Kidney Dis 46 (2005) 871-880
6. Hunsicker L.G., Adler S., Caggiula A., et al. Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. Kidney Int 51 (1997) 1908-1919
7. Muntner P., Coresh J., Smith J.C., Eckfeldt J., and Klag M.J. Plasma lipids and risk of developing renal dysfunction: The Atherosclerosis Risk in Communities Study. Kidney Int 58 (2000) 293-301
8. Chen J., Muntner P., Hamm L.L., et al. The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med 140 (2004) 167-174
9. Vaziri N.D. Dyslipidemia of chronic renal failure: The nature, mechanisms, and potential consequences. Am J Physiol Renal Physiol 290 (2006) F262-F272
10. Grundy S.M., Brewer Jr. H.B., Cleeman J.I., Smith Jr. S.C., and Lenfant C. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109 (2004) 433-438
11. Chen J., Muntner P., Hamm L.L., et al. Insulin resistance and risk of chronic kidney disease in nondiabetic US adults. J Am Soc Nephrol 14 (2003) 469-477
12. Kurella M., Lo J.C., and Chertow G.M. Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol 16 (2005) 2134-2140
13. Hsu C.Y., McCulloch C.E., Iribarren C., Darbinian J., and Go A.S. Body mass index and risk for end-stage renal disease. Ann Intern Med 144 (2006) 21-28
14. Iseki K., Ikemiya Y., Kinjo K., Inoue T., Iseki C., and Takishita S. Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int 65 (2004) 1870-1876
15. Kramer H.J., Saranathan A., Luke A., et al. Increasing body mass index and obesity in the incident ESRD population. J Am Soc Nephrol 17 (2006) 1453-1459
16. Anderwald C., and Roden M. Adipotoxicity and the insulin resistance syndrome. Pediatr Endocrinol Rev 1 (2004) 310-319
17. Mekki K., Bouchenak M., Lamri M., Remaoun M., and Belleville J. Changes in plasma lecithin: Cholesterol acyltransferase activity, HDL(2), HDL(3) amounts and compositions in patients with chronic renal failure after different times of hemodialysis. Atherosclerosis 162 (2002) 409-417
18. Mekki K., Bouchenak M., Remaoun M., and Belleville J.L. Effect of long-term hemodialysis on plasma lecithin: Cholesterol acyltransferase activity and the amounts and compositions of HDL2 and HDL3 in hemodialysis-treated patients with chronic renal failure: A 9-year longitudinal study. Med Sci Monit 10 (2004) CR439-CR446
19. Miida T., Miyazaki O., Hanyu O., et al. LCAT-dependent conversion of prebeta1-HDL into alpha-migrating HDL is severely delayed in hemodialysis patients. J Am Soc Nephrol 14 (2003) 732-738
20. Go A.S., Chertow G.M., Fan D., McCulloch C.E., and Hsu C.Y. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351 (2004) 1296-1305
21. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., and Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130 (1999) 461-470
22. Levey A.S., Greene T., Kusek J.W., and Beck G.J. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol 11 (2000) 155A (abstr)
23. Landis J.R., Gaughan C., Joffe M., and Investigators ftCS. Inter-laboratory serum creatinine (sCr) calibration study. J Am Soc Nephrol 14 (2003) 294A (abstr)
24. Lo J.C., Feigenbaum S.L., Yang J., Pressman A.R., Selby J.V., and Go A.S. Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome. J Clin Endocrinol Metab 91 (2006) 1357-1363
25. Grundy S.M., Cleeman J.I., Daniels S.R., et al. Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112 (2005) 2735-2752
26. Muntner P., Hamm L.L., Kusek J.W., Chen J., Whelton P.K., and He J. The prevalence of nontraditional risk factors for coronary heart disease in patients with chronic kidney disease. Ann Intern Med 140 (2004) 9-17
27. Eberly L.E., Prineas R., Cohen J.D., et al. Metabolic syndrome: Risk factor distribution and 18-year mortality in the Multiple Risk Factor Intervention Trial. Diabetes Care 29 (2006) 123-130
28. Lo J.C., Chertow G.M., Go A.S., and Hsu C.Y. Increased prevalence of subclinical and clinical hypothyroidism in persons with chronic kidney disease. Kidney Int 67 (2005) 1047-1052